01 6GlaxoSmithKline Inc.
01 22201785
02 22669536
03 22814518
01 6Ambrisentan
01 6Tablet
01 22015-10-07
02 22027-12-11
03 22031-10-14
Patent Expiration Date : 2015-10-07
Date Granted : 2006-08-29
Brand Name : VOLIBRIS
Patent Number : 2201785
Filing Date : 1995-10-07
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2015-10-07
Date Granted : 2006-08-29
Patent Expiration Date : 2015-10-07
Date Granted : 2006-08-29
Brand Name : VOLIBRIS
Patent Number : 2201785
Filing Date : 1995-10-07
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2015-10-07
Date Granted : 2006-08-29
Patent Expiration Date : 2031-10-14
Date Granted : 2016-09-20
Brand Name : VOLIBRIS
Patent Number : 2814518
Filing Date : 2011-10-14
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2031-10-14
Date Granted : 2016-09-20
Patent Expiration Date : 2027-12-11
Date Granted : 2016-05-31
Brand Name : VOLIBRIS
Patent Number : 2669536
Filing Date : 2007-12-11
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2027-12-11
Date Granted : 2016-05-31
Patent Expiration Date : 2031-10-14
Date Granted : 2016-09-20
Brand Name : VOLIBRIS
Patent Number : 2814518
Filing Date : 2011-10-14
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2031-10-14
Date Granted : 2016-09-20
Patent Expiration Date : 2027-12-11
Date Granted : 2016-05-31
Brand Name : VOLIBRIS
Patent Number : 2669536
Filing Date : 2007-12-11
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : oral
Patent Expiration Date : 2027-12-11
Date Granted : 2016-05-31
LOOKING FOR A SUPPLIER?
